Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
The global Molecular Biological Reagents market size was valued at USD 10766.26 Million in 2022 and will reach USD 16665.84 Million in 2028, with a CAGR of 7.55% during 2022-2028.
Molecular biology reagents provide researchers in academia and industry with consistent, robust, and accurate results. Molecular biology reagents are widely used to detect genetic material in cells and tissues. Examples include DNA and RNA analysis, gene expression, biochemical analysis, and protein export. They are also used in experiments or sample preparation, such as nucleic acid preparation, extraction, purification, and labeling of products.
Increased burden of infectious and genetic disease
Molecular diagnostics play an important role in many areas of pathology, but their importance in infectious and genetic diseases cannot be underestimated. Thanks to the simplicity and widespread use of PCR, molecular techniques are now available for a variety of applications in routine clinical laboratories. Molecular diagnostic tools have the advantage of identifying specific organisms, and real-time PCR can quickly detect a variety of infectious microorganisms, providing high-quality nucleic acid extraction, sensitive detection, and accurate quantification, enabling laboratories to reduce costs and achieve better results. According to the World Health Organization, approximately 12,368 people tested positive for the influenza virus between January 24, 2022, and February 6, 2022. At the same time, according to the World Health Organization's 2021 report, Southeast Asia and Africa account for 43% and 25% of global TB cases, respectively. Sub-Saharan Africa is projected to bear the burden of malaria, accounting for approximately 95% of all malaria cases and 96% of all deaths. Hence, rising cases of infectious diseases will increase the demand for molecular biological reagents for diagnostic and therapeutic purposes, thereby driving the market growth. Furthermore, the rising number of babies with Down syndrome is expected to increase the demand for genetic testing, likewise driving market growth. For example, more than 6,000 babies with Down syndrome are born in the United States each year. Therefore, the increasing burden of infectious and genetic diseases will increase the market demand for molecular biological reagents.
Increase in Gene Sequencing
A few years ago, genome sequencing was limited to research facilities. However, it has now become one of the most commonly used techniques in clinical practice. Significant growth of the molecular biology reagents market is propelled by the significant reduction in the cost of genetic analysis leading to major developments in the fields of disease treatment, microbial genetics, and personalized medicine. Genetic information obtained through sequencing technologies contains massive datasets and confidential personal information. These genomic databases, when legally stored and processed, can help researchers understand the genetic basis of disease and its progression at the cellular level. R&D projects in the field of gene sequencing have increased the demand for molecular biotechnology tools such as enzymes and other proteins. The growing popularity of genome sequencing in the healthcare system has been supported by substantial investment from many governments. The UK, for example, announced the world's largest genome project as part of a $200m public-private partnership between charities and pharmaceutical companies. China has established the world's largest genome database through the 100,000-person plan, which aims to support researchers and industry through funding to combine data and real-world evidence obtained from the UK health service and create new products and services to improve efficiency and early Disease diagnosis. In response to the growing global demand for gene sequencing technology, molecular biology reagent companies are constantly developing and launching new products. For example, Jumpcode Genomics has launched the CRISPRclean Single Cell RNA Boost Kit. The technology removes uninformative sequences and improves single-cell experiments by providing better insights from genomic data. Therefore, the increase in gene sequencing activities is beneficial to the development of the molecular biology reagents industry.
Technological progress drives product innovation
Technological innovation has continuously promoted the development and progress of the life sciences field, and the increase in the types of molecular biology reagents has also promoted the expansion of downstream application fields. In 2022, Kaneka Corporation released the KANEKA RT-PCR Kit "SARS-CoV-2 (Omicron/Delta) ver.2", a real-time PCR detection kit capable of simultaneously detecting Omicron (BA.1), "Stealth "Omicron (BA.2) and the Delta variant of COVID-19. The detection kit uses proprietary reagents developed by Kaneka Molecular Detection Technology to detect the presence of three variants with a single PCR test. This is expected to help reduce the burden of testing and facilitate the selection of the most appropriate drugs and treatments for each variant in the clinical setting. In March 2022, Illumina launched the TruSight Oncology (TSO) comprehensive in vitro genomic analysis kit, which evaluates multiple genes and biomarkers to reveal specific molecular signatures of cancer patients in Europe. This will help clinicians provide specific treatments to patients based on molecular profiles. In 2021 Genes2Me launched a Molecular Biology product range to accelerate and support bioscience research in India. The newly launched product range includes product categories such as Enzyme Technology, Cloning, Next Generation Sequencing, and Polymerase Chain Reaction. The expansion of application fields also contributes to expanding demand for biological reagents. For example, mRNA technology extends from the field of new crown vaccines to other fields such as tumor vaccines. The application of NGS technology in the fields of companion diagnosis and non-invasive prenatal diagnosis has been continuously enriched, which has generated a large demand for supporting biological reagents. All in all, with the development of new technologies in the field of life sciences, the scope of demand for corresponding supporting molecular biological reagents will continue to expand, and the market size of molecular biological reagents will also expand according.
Region Overview:
In 2021, the share of the Molecular Biological Reagents market in North America stood at 44.96%.
Company Overview:
Thermo Fisher, QIAGEN, Bio-Rad were the top 3 players in the Molecular Biological Reagents market in 2022, taking up a market share of 35.75% together.
Segmentation Overview:
By type, Enzyme segment accounted for the largest share of market in 2021.
Application Overview:
By application, the Pharmaceutical & Biotechnology Companies segment occupied the biggest share from 2017 to 2022.
The Molecular Biological Reagents market report covers sufficient and comprehensive data on market introduction, segmentations, status and trends, opportunities and challenges, industry chain, competitive analysis, company profiles, and trade statistics, etc. It provides in-depth and all-scale analysis of each segment of types, applications, players, 5 major regions and sub-division of major countries, and sometimes end user, channel, technology, as well as other information individually tailored before order confirmation.
Meticulous research and analysis were conducted during the preparation process of the report. The qualitative and quantitative data were gained and verified through primary and secondary sources, which include but not limited to Magazines, Press Releases, Paid Databases, Maia Data Center, National Customs, Annual Reports, Public Databases, Expert interviews, etc. Besides, primary sources include extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs, and marketing executives, downstream distributors, as well as end-clients.
In this report, the historical period starts from 2018 to 2022, and the forecast period ranges from 2023 to 2028. The facts and data are demonstrated by tables, graphs, pie charts, and other pictorial representations, which enhances the effective visual representation and decision-making capabilities for business strategy.
Key Companies in the global Molecular Biological Reagents market covered in Chapter 4:
Yeasen Biotechnology
New England Biolabs (NEB)
Roche
Vazyme
Genscript
QIAGEN
Thermo Fisher
ABclonal Technology
Bio-Rad
TransGen Biotech
Promega Corporation
CWBIO
Takara
In Chapter 12 and Chapter 14.1, on the basis of types, the Molecular Biological Reagents market from 2018 to 2028 is primarily split into:
Enzyme
Nucleic Acid
Carrier
Others
In Chapter 13 and Chapter 14.2, on the basis of the Downstream Industry, the Molecular Biological Reagents market from 2018 to 2028 covers:
College
Pharmaceutical Company
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, history and forecast (2018-2028) of the following regions are covered in Chapters 6, 7, 8, 9, 10, 11, 15:
North America (United States, Canada, Mexico)
Europe (Germany, United Kingdom, France, Italy, Spain)
Asia Pacific (China, Japan, South Korea, India, Southeast Asia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, South Africa)
Outline:
Chapter 1 begins with the Molecular Biological Reagents market scope and definition, product segment introduction, global overall market size, as well as market dynamics scenarios such as opportunities, challenges, and industry development trends under inflation. It offers a high-level view of the current state of the Molecular Biological Reagents market and its likely evolution in the short to mid-term and long term.
Chapter 2 provides Molecular Biological Reagents industry chain analysis, covering raw materials analysis, cost structure, price estimate, and forecast, along with price-impacting factors, downstream channels, and major customers. It aims to help readers to grab insights into product upstream, midstream, and downstream fields.
Chapter 3 depicts Molecular Biological Reagents industry competitive analysis regarding market concentration rate, saturation rate, feasibility analysis from new entrants, as well as substitute's status and trends. It indicates the developing space and prospects of the current industry.
Chapter 4 analyzes extensive company profiles, comprising company basic info, product or service profiles, and sales, price, value, gross, and gross margin 2018-2023. It incorporates the Molecular Biological Reagents market ranking, benchmarks, and company business portfolio.
Chapter 5 presents trade statistics of import and export volume from 2018-2023, demonstrating domestic and international market comparisons in specific countries.
Chapters 6-10 highlight Molecular Biological Reagents market status at the regional and country levels, including 5 major regions of North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. The region and country list in the sample is only for reference, and it can be adjusted as required.
Chapter 11 involves geographical market figures of sales, value, market share, and growth rate. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of each specific region.
Chapters 12-13 evaluate the Molecular Biological Reagents market based on different types and applications. It focuses on sales and value of 2018-2023 from both vertical and horizontal perspectives.
Chapters 14-15 elaborate on the Molecular Biological Reagents market forecast data from 2023-2028, segmented by types and applications, regions, and major countries, helping readers to know future aspects and growth trends.
Chapter 16 ends with an elaboration of data sources and research methodology. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Molecular biology reagents provide researchers in academia and industry with consistent, robust, and accurate results. Molecular biology reagents are widely used to detect genetic material in cells and tissues. Examples include DNA and RNA analysis, gene expression, biochemical analysis, and protein export. They are also used in experiments or sample preparation, such as nucleic acid preparation, extraction, purification, and labeling of products.
Increased burden of infectious and genetic disease
Molecular diagnostics play an important role in many areas of pathology, but their importance in infectious and genetic diseases cannot be underestimated. Thanks to the simplicity and widespread use of PCR, molecular techniques are now available for a variety of applications in routine clinical laboratories. Molecular diagnostic tools have the advantage of identifying specific organisms, and real-time PCR can quickly detect a variety of infectious microorganisms, providing high-quality nucleic acid extraction, sensitive detection, and accurate quantification, enabling laboratories to reduce costs and achieve better results. According to the World Health Organization, approximately 12,368 people tested positive for the influenza virus between January 24, 2022, and February 6, 2022. At the same time, according to the World Health Organization's 2021 report, Southeast Asia and Africa account for 43% and 25% of global TB cases, respectively. Sub-Saharan Africa is projected to bear the burden of malaria, accounting for approximately 95% of all malaria cases and 96% of all deaths. Hence, rising cases of infectious diseases will increase the demand for molecular biological reagents for diagnostic and therapeutic purposes, thereby driving the market growth. Furthermore, the rising number of babies with Down syndrome is expected to increase the demand for genetic testing, likewise driving market growth. For example, more than 6,000 babies with Down syndrome are born in the United States each year. Therefore, the increasing burden of infectious and genetic diseases will increase the market demand for molecular biological reagents.
Increase in Gene Sequencing
A few years ago, genome sequencing was limited to research facilities. However, it has now become one of the most commonly used techniques in clinical practice. Significant growth of the molecular biology reagents market is propelled by the significant reduction in the cost of genetic analysis leading to major developments in the fields of disease treatment, microbial genetics, and personalized medicine. Genetic information obtained through sequencing technologies contains massive datasets and confidential personal information. These genomic databases, when legally stored and processed, can help researchers understand the genetic basis of disease and its progression at the cellular level. R&D projects in the field of gene sequencing have increased the demand for molecular biotechnology tools such as enzymes and other proteins. The growing popularity of genome sequencing in the healthcare system has been supported by substantial investment from many governments. The UK, for example, announced the world's largest genome project as part of a $200m public-private partnership between charities and pharmaceutical companies. China has established the world's largest genome database through the 100,000-person plan, which aims to support researchers and industry through funding to combine data and real-world evidence obtained from the UK health service and create new products and services to improve efficiency and early Disease diagnosis. In response to the growing global demand for gene sequencing technology, molecular biology reagent companies are constantly developing and launching new products. For example, Jumpcode Genomics has launched the CRISPRclean Single Cell RNA Boost Kit. The technology removes uninformative sequences and improves single-cell experiments by providing better insights from genomic data. Therefore, the increase in gene sequencing activities is beneficial to the development of the molecular biology reagents industry.
Technological progress drives product innovation
Technological innovation has continuously promoted the development and progress of the life sciences field, and the increase in the types of molecular biology reagents has also promoted the expansion of downstream application fields. In 2022, Kaneka Corporation released the KANEKA RT-PCR Kit "SARS-CoV-2 (Omicron/Delta) ver.2", a real-time PCR detection kit capable of simultaneously detecting Omicron (BA.1), "Stealth "Omicron (BA.2) and the Delta variant of COVID-19. The detection kit uses proprietary reagents developed by Kaneka Molecular Detection Technology to detect the presence of three variants with a single PCR test. This is expected to help reduce the burden of testing and facilitate the selection of the most appropriate drugs and treatments for each variant in the clinical setting. In March 2022, Illumina launched the TruSight Oncology (TSO) comprehensive in vitro genomic analysis kit, which evaluates multiple genes and biomarkers to reveal specific molecular signatures of cancer patients in Europe. This will help clinicians provide specific treatments to patients based on molecular profiles. In 2021 Genes2Me launched a Molecular Biology product range to accelerate and support bioscience research in India. The newly launched product range includes product categories such as Enzyme Technology, Cloning, Next Generation Sequencing, and Polymerase Chain Reaction. The expansion of application fields also contributes to expanding demand for biological reagents. For example, mRNA technology extends from the field of new crown vaccines to other fields such as tumor vaccines. The application of NGS technology in the fields of companion diagnosis and non-invasive prenatal diagnosis has been continuously enriched, which has generated a large demand for supporting biological reagents. All in all, with the development of new technologies in the field of life sciences, the scope of demand for corresponding supporting molecular biological reagents will continue to expand, and the market size of molecular biological reagents will also expand according.
Region Overview:
In 2021, the share of the Molecular Biological Reagents market in North America stood at 44.96%.
Company Overview:
Thermo Fisher, QIAGEN, Bio-Rad were the top 3 players in the Molecular Biological Reagents market in 2022, taking up a market share of 35.75% together.
Segmentation Overview:
By type, Enzyme segment accounted for the largest share of market in 2021.
Application Overview:
By application, the Pharmaceutical & Biotechnology Companies segment occupied the biggest share from 2017 to 2022.
The Molecular Biological Reagents market report covers sufficient and comprehensive data on market introduction, segmentations, status and trends, opportunities and challenges, industry chain, competitive analysis, company profiles, and trade statistics, etc. It provides in-depth and all-scale analysis of each segment of types, applications, players, 5 major regions and sub-division of major countries, and sometimes end user, channel, technology, as well as other information individually tailored before order confirmation.
Meticulous research and analysis were conducted during the preparation process of the report. The qualitative and quantitative data were gained and verified through primary and secondary sources, which include but not limited to Magazines, Press Releases, Paid Databases, Maia Data Center, National Customs, Annual Reports, Public Databases, Expert interviews, etc. Besides, primary sources include extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs, and marketing executives, downstream distributors, as well as end-clients.
In this report, the historical period starts from 2018 to 2022, and the forecast period ranges from 2023 to 2028. The facts and data are demonstrated by tables, graphs, pie charts, and other pictorial representations, which enhances the effective visual representation and decision-making capabilities for business strategy.
Key Companies in the global Molecular Biological Reagents market covered in Chapter 4:
Yeasen Biotechnology
New England Biolabs (NEB)
Roche
Vazyme
Genscript
QIAGEN
Thermo Fisher
ABclonal Technology
Bio-Rad
TransGen Biotech
Promega Corporation
CWBIO
Takara
In Chapter 12 and Chapter 14.1, on the basis of types, the Molecular Biological Reagents market from 2018 to 2028 is primarily split into:
Enzyme
Nucleic Acid
Carrier
Others
In Chapter 13 and Chapter 14.2, on the basis of the Downstream Industry, the Molecular Biological Reagents market from 2018 to 2028 covers:
College
Pharmaceutical Company
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, history and forecast (2018-2028) of the following regions are covered in Chapters 6, 7, 8, 9, 10, 11, 15:
North America (United States, Canada, Mexico)
Europe (Germany, United Kingdom, France, Italy, Spain)
Asia Pacific (China, Japan, South Korea, India, Southeast Asia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, South Africa)
Outline:
Chapter 1 begins with the Molecular Biological Reagents market scope and definition, product segment introduction, global overall market size, as well as market dynamics scenarios such as opportunities, challenges, and industry development trends under inflation. It offers a high-level view of the current state of the Molecular Biological Reagents market and its likely evolution in the short to mid-term and long term.
Chapter 2 provides Molecular Biological Reagents industry chain analysis, covering raw materials analysis, cost structure, price estimate, and forecast, along with price-impacting factors, downstream channels, and major customers. It aims to help readers to grab insights into product upstream, midstream, and downstream fields.
Chapter 3 depicts Molecular Biological Reagents industry competitive analysis regarding market concentration rate, saturation rate, feasibility analysis from new entrants, as well as substitute's status and trends. It indicates the developing space and prospects of the current industry.
Chapter 4 analyzes extensive company profiles, comprising company basic info, product or service profiles, and sales, price, value, gross, and gross margin 2018-2023. It incorporates the Molecular Biological Reagents market ranking, benchmarks, and company business portfolio.
Chapter 5 presents trade statistics of import and export volume from 2018-2023, demonstrating domestic and international market comparisons in specific countries.
Chapters 6-10 highlight Molecular Biological Reagents market status at the regional and country levels, including 5 major regions of North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. The region and country list in the sample is only for reference, and it can be adjusted as required.
Chapter 11 involves geographical market figures of sales, value, market share, and growth rate. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of each specific region.
Chapters 12-13 evaluate the Molecular Biological Reagents market based on different types and applications. It focuses on sales and value of 2018-2023 from both vertical and horizontal perspectives.
Chapters 14-15 elaborate on the Molecular Biological Reagents market forecast data from 2023-2028, segmented by types and applications, regions, and major countries, helping readers to know future aspects and growth trends.
Chapter 16 ends with an elaboration of data sources and research methodology. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Years considered for this report:
Historical Years:
2018-2022Base Year:
2022Estimated Year:
2023Forecast Period:
2023-2028Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
